Differential expression of nesfatin-1 in intestinal tissues of premature infants with necrotizing enterocolitis and and its mechanism

AIM To analyze the expression of nesfatin-1 in intestinal tissues of premature infants with necrotizing enterocolitis （NEC）， and to explore the effect of nesfatin-1 on lipopolysacharide （LPS）-induced enterocytes and its mechanism. METHODS The intestinal tissues were obtained from infants who underwent intestinal surgery for NEC in our hospital from 2017 to 2019. The mRNA expression of nesfatin-1 in the tissue samples of NEC were evaluated by RT-qPCR. Human fetal normal colon epithelial HCoEpiC cells and human colon cancer Caco-2 cells were used as research objects. The effect of nesfatin-1 on the secretion of cytokines was measured by ELISA. Western blot was used to analyze the protein expression of nesfatin-1 and Toll-like receptor 4 （TLR4）， NLRP3， AIM2， caspase-1 and ASC， and co-immunoprecipitation assay were conducted to explore the relation between nesfatin-1 and TLR4. RESULTS The expression of nesfatin-1 in NEC preterm infants was significantly lower than that in the healthy group （P<0.01）. Compared with control group， the expression of nesfatin-1 in HCo Epic cells and HT-29 cells induced by LPS was decreased （P<0.01）， while the transfection of nesfatin-1 reversed the stimulation of LPS， and the over-expression of nesfatin-1 decreased the levels of tumor necrosis factor-α （TNF-α） and interleukin-6 （IL-6）， and increased the level of IL-10 （P<0.05）. In addition， nesfatin-1 over-expression inhibited the expression of NLRP3， AIM2， caspase-1 and ASC. The expression of TLR4 in NEC tissue samples was significantly higher than that in healthy infants （P<0.05）. Pearson correlation analysis showed that there was a significant negative correlation between nesfatin-1 and TLR4 （r=-0.816， P<0.01）. TLR4 was found to co-precipitate with nesfatin-1. CONCLUSION Nesfatin-1 protects intestinal cells from LPS induced inflammation by targeting TLR4， which may be a potential target of anti-NEC therapy.     

Metagenomic Investigation of Idiopathic Meningoencephalomyelitis in Dogs

Background

Meningoencephalomyelitis of unknown origin (MUO) is a common and life‐threatening neuroinflammatory disease in dogs. Features of the disease are suggestive of an underlying immune‐mediated process, but the association of this disease with a pathogen is still unknown.

Hypothesis/Objectives

To search for candidate etiologic agent associated with cases if MUO using next generation metagenomic sequencing.

Animals

Twenty‐two dogs diagnosed with either MUO (11/22; 10 CSF and 3 brain), or noninflammatory CNS diseases inconsistent with MUO (11/22; 11 CSF and 2 brain) that served as negative controls.

Methods

A case control study was performed by identifying MUO and non‐MUO cases. Samples were blindly processed and then unblinded for comparative analyses. Inclusion criteria for MUO cases included consistent MRI lesions and inflammatory CSF with a negative PCR panel for infectious agents or histopathologic diagnosis. Dogs with glucocorticoid therapy within 2 weeks of sample collection were excluded. Fresh‐frozen cerebrospinal fluid (CSF; 21) and brain (5) samples were collected and RNA and DNA were extracted separately for shotgun metagenomic sequencing. Known positive samples were used as controls to validate our sequencing and analysis pipelines and to establish limits of detection. Sequencing results were analyzed at a nucleotide and protein level for broad comparison to known infectious organisms.

Results

No candidate etiologic agents were identified in dogs with MUO.

Conclusions and Clinical Importance

These results support but do not prove the hypothesis that MUO is not associated with infectious agents and might be an autoimmune disease.     

A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool

Background

A plethora of treatment options have been described for canine meningoencephalitis of unknown origin (MUO), yet a gold standard has not been established. The aim of this prospective pilot study was to document the effect of a newly designed 30 Gray (Gy) radiation therapy (RT) protocol plus corticosteroids as treatment for focal and multifocal MUO, to monitor clinical and imaging changes during the course of the disease with conventional magnetic resonance imaging (MRI) and proton MR Spectroscopy (H-1 MRS) and to detect the occurrence of radiation related side effects.

Results

Six dogs (3 with focal and 3 with multifocal lesions) were included in the study. The RT protocol used consisted of 30 Gy in 10 fractions. The neurological status of all six dogs improved during RT, with 3 of 6 cases returning to a normal condition. One dog was euthanized early during follow-up (<3 weeks after end of RT). Three month follow up MRI was normal in one dog and improved in 3 dogs and H-1 MRS normalized in 4. In the dog without improvement of the MRI lesions, the N-acetyl aspartate continued to decrease, while choline and creatine concentrations remained stable during that time. This dog was euthanized 18 month after the end of RT due to relapse. One dog was lost to follow up 12 month after completion of RT. The other 3 dogs are still alive at the time of writing.

Conclusions

RT with 30 Gy in 10 fractions can provide an additional option for anti-inflammatory treatment of focal and multifocal MUO. The protocol used for treatment monitoring was feasible while no side effects of RT could be observed during the follow up period. Moreover, H-1 MRS could represent a new and non-invasive tool to control the progression of the disease during the treatment course.     

对虾肝胰腺坏死性细菌研究进展

坏死性肝胰腺炙（Necrotizing hepatopancreatiris,NHP）对世界对虾养殖业危害极大。NHP是由一种专性细胞内寄生的革兰氏阴性菌——肝胰腺坏死性细菌（Necrotizing hepatopancreatitis bacterium,NHPB）引起的。NHPB是一种类立克次体的a蛋白菌。目前在美洲中部和南部的几个国家蔓延,受感染的虾池其对虾的死亡率可高达95%。目前已被世界动物卫生组织（OIE）列入高危病原。文章综述了NHPB研究进展,对NHPB的形态特征、理化特性、引起的症状和病理变化、检测方法和防治等问题进行了介绍。     

Heritability and transmission analysis of necrotizing meningoencephalitis in the Pug

Necrotizing meningoencephalitis (NME) in the Pug is an invariably fatal disease with an early age of onset whose cause remains unknown. Breed predilection strongly suggests genetic component(s), and viral etiology proves negative in studied cases. The current study was undertaken as the first analysis of the heritable component(s) involved in NME in the Pug. Complete medical records, individual characteristics, and pedigree information were collected for 58 affected dogs with data pertaining to 4698 dogs analyzed. A high inbreeding coefficient with differences across gender and significant differences across coat color classes and variable expression was evident. Median onset age was 19 months and median survival time 23 days. Screening for herpes-, adeno-, and parvoviruses was negative. The data demonstrate a strong familial inheritance of NME in the Pug. This investigation provides parameters of disease from the largest Pug NME cohort analyzed to date and offers evidence of previously unrecognized familial inheritance.     

The Impact of Demographic,Social, and Environmental Factors on the Development of Steroid‐Responsive Meningitis‐Arteritis (SRMA) in the United Kingdom

Background

Steroid‐responsive meningitis‐arteritis (SRMA) is an inflammatory disease of dogs that is suspected to be immune‐mediated. The development of other immune‐mediated diseases has been linked to vaccinations, time of the year, geographic location, sex, neuter status, and breed.

Hypothesis/Objectives

To identify if the development of SRMA is associated with time of year, vaccination, geographic location, sex, neuter status, and breed.

Animals

Sixty SRMA cases and 180 controls, all ≤24 months of age and matched for year of presentation, from a referral hospital population in the United Kingdom.

Methods

Retrospective case‐control study with unconditional logistic regression analysis.

Results

Beagles (P = .001), Border Collies (P = .001), Boxers (P = .032), Jack Russell Terriers (P = .001), Weimaraners (P = .048), and Whippets (P < .001) had significantly greater odds of developing SRMA in this population of dogs. Vaccination, time of year, geographic category, sex, and neuter status did not increase the odds of developing SRMA.

Conclusions and Clinical Importance

Only breed increased the odds of developing SRMA. It would be prudent to investigate the genetics of the identified breeds to help elucidate the etiopathogenesis of SRMA.